MEDIUM confidence: 100% data completeness, but the composite (57) sits in the indecisive 30–70 range — strong-buy and short calls require a more decisive composite. What does confidence mean?
Technical context for active traders — derived from price, the 50/200-day moving averages, the 52-week range, and recent volume. Not part of the QScore.
AI classification of policy/regulatory sensitivity from the company's sector, industry, and business description. Exposure/sensitivity only — not a political opinion, a prediction of government action, or investment advice. As of 2026-07-10.
Dated events from the market calendar; the “also watch” items are AI-generated observations from QScoring data. Informational only — not investment advice, and dates can change.
Fama-French 5-factor (2×3) + Momentum, monthly OLS with Newey-West errors. Bars show signed factor betas; faded bars/figures aren't statistically significant.
Net insider -$10.1M over 180 days (0 open-market buys, 3 sells). Insider buying is the informative signal; routine selling is normal.
Short interest, days-to-cover, and institutional-ownership change require a data-plan upgrade (not yet available).
Forward-return IC, quintile spread & hit rate publish on /performance as the tracking panel accrues enough no-look-ahead history.
Net buyback (repurchases less issuance) ÷ market cap, plus trailing dividend yield.
Fewer than 3 analysts refreshed a price target in the last month, so no revision can be computed. Prior quarter: $98 avg across 4 analysts.
Buy-rated share 65% → 62% over ~3 months (-4pp).
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jul 2026 | $1.73 | $1.96 | +13.3% |
| Apr 2026 | $1.58 | $1.56 | -1.3% |
| Jan 2026 | $1.66 | $1.62 | -2.4% |
| Oct 2025 | $1.55 | $1.73 | +11.6% |
| Jul 2025 | $1.41 | $1.54 | +9.2% |
| Apr 2025 | $1.23 | $1.27 | +3.3% |
| Jan 2025 | $1.32 | $1.42 | +7.6% |
| Oct 2024 | $1.28 | $1.52 | +18.8% |
| Metric (USD) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $83.1B— | $83.4B+0.4% | $115.3B+38.2% | $125.4B+8.7% | $123.5B-1.5% |
| EPS (dil.) | $4.99— | $3.14-37.1% | $4.83+53.8% | $5.37+11.2% | $6.32+17.7% |
| Free Cash Flow | -$11.5B— | $27.0Bn/m | $40.4B+49.2% | $3.0B-92.5% | -$19.0B-726.1% |
| Gross Margin | 100.3% | 87.3%-13.0pp | 66.9%-20.4pp | 62.2%-4.8pp | 64.8%+2.6pp |
| Operating Margin | 35.6% | 18.7%-16.9pp | 18.8%+0.0pp | 18.6%-0.1pp | 20.4%+1.8pp |
| Net Margin | 26.6% | 16.4%-10.2pp | 16.6%+0.2pp | 15.7%-0.9pp | 17.3%+1.5pp |
Absolute figures with year-over-year change. Margins show the level with the change in percentage points (pp). “n/m” = not meaningful (prior ≤ 0); ⚠ marks a large percentage off a small base — read the dollar figure.
Working the DCF backward: holding the assumptions below, this is the free-cash-flow growth today's price implies over the next 10 years. It is a read on the price's embedded expectations — not a fair-value or target price.
The price implies FCF growth above the analyst consensus of 11.4%/yr (revenue basis).
Base free cash flow $8.1B (avg FY2023–FY2025; latest year -$19.0B) · equity value $267.9B · levered FCF discounted at the cost of equity. Reverse DCF is illustrative, not advice.
The QScore of 57 for Wells Fargo indicates a neutral outlook, with the stock's value and momentum scores driving it up, while growth and profitability scores pull it down. The stock trades at a reasonable valuation, with a P/E of 12.6, and exhibits strong momentum, having risen 20.7% over the past three months. In contrast, its growth score is hindered by a significant decline in free cash flow growth, at -726.1%. The long-term and short-term scores are relatively aligned, with only a 3-point difference.